Skip to content

Manual Therapy Treatment for Myofascial Pain

Effect of Manual Therapy After Trigger Point Injection for Myofascial Pain Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01381380
Enrollment
30
Registered
2011-06-27
Start date
2006-11-30
Completion date
2009-12-31
Last updated
2011-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndromes

Keywords

myofascial pain, trigger point injection, manual therapy

Brief summary

This study is a pain intensity evaluation in patients with myofascial pain submitted kinesitherapy after trigger point injection.

Detailed description

Randomized prospective study conducted on 30 patients of both genders ranging in age from 18 to 60 years, with neck and shoulder girdle Myofascial Pain Syndrome (MFS), with a duration of ≥ 4 months and pain intensity ≥ 4. Trigger point injection of 1 mL 0.25% bupivacaine at each point, once a week for 8 weeks (T1 to T8). Group 1: kinesiotherapy once a week for 8 weeks Group 2: not submitted to kinesiotherapy Evaluation of pain intensity on the first assessment (T0) and after 1, 2, 3, 4, 5, 6, 7, 8, and 9 weeks

Interventions

PROCEDUREManual therapy

Manual therapy, once a week for 8 weeks

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* myofascial pain of neck and shoulder girdle, lasting ≥ 4 months, pain intensity ≥ 4.

Exclusion criteria

* arrhythmia * heart block * coagulopathy * cognitive alterations and infection at the site * patients using anticoagulants, and pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity8 weeksonce a week for 8 weeks (T1 to T8)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026